# RAS-Peptide-Profile Study in Healthy Male Subjects

> **NCT01771783** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 12 (actual)

## Conditions studied

- RAS Peptide Profile in Healthy Volunteers

## Interventions

- **DRUG:** ACEI-ARB-RI
- **DRUG:** ARB-RI-ACEI
- **DRUG:** RI-ACEI-ARB

## Key facts

- **NCT ID:** NCT01771783
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-04
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01771783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01771783, "RAS-Peptide-Profile Study in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01771783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*